Collegium Pharmaceutical (COLL) EBT Margin (2016 - 2026)

Collegium Pharmaceutical's EBT Margin history runs 11 years deep, the most recent figure standing at 9.68% for Q1 2026.

• In Q1 2026, EBT Margin rose 793.0% year-over-year to 9.68%; the TTM figure through Mar 2026 stood at 13.59% (up 91.0% YoY), while the FY2025 annual figure was 11.87%, down 374.0% from the prior year.
• EBT Margin was 9.68% for Q1 2026 at Collegium Pharmaceutical, down from 14.13% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 195.7% in Q3 2024 to a low of 435.82% in Q1 2022.
• Historically, EBT Margin has averaged 5.12% across 5 years, with a median of 9.68% in 2026.
• The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 45346 bps in 2022, then jumped 42369 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 6.01% in 2022, then surged by 619 bps to 31.19% in 2023, then tumbled by 70 bps to 9.49% in 2024, then jumped by 49 bps to 14.13% in 2025, then tumbled by 31 bps to 9.68% in 2026.
• The last three EBT Margin figures came in at 9.68% (Q1 2026), 14.13% (Q4 2025), and 20.75% (Q3 2025), per Business Quant data.